September 30, 2025

LivaNova PLC (LIVN) Stock Analysis: Exploring a 24% Potential Upside in the Medical Devices Arena

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, has captured the attention of investors with its innovative contributions to the medical devices industry...

PACS Group, Inc. (PACS) Stock Analysis: A 150% Upside Potential in the Healthcare Sector

PACS Group, Inc. (PACS), a significant player in the healthcare sector, is capturing investor attention with its remarkable potential for growth. As a medical care facilities..

Omnicell, Inc. (OMCL) Stock Analysis: Potential Upside of 45% Captures Investor Attention

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, is making waves with a promising potential upside of 45.02%, according to recent analyst ratings...

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Eyeing a 41.66% Potential Upside with Promising Pipeline

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a U.S.-based biopharmaceutical company, is at the forefront of developing innovative therapies for retinal diseases and other ocular conditions. With a..

Sotera Health Company (SHC) Stock Analysis: Understanding Its Modest 1.59% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Dynavax Technologies (DVAX) Stock Analysis: Unveiling a Potential 136% Upside for Investors

As the global healthcare sector continues to expand, Dynavax Technologies Corporation (NASDAQ: DVAX) emerges as a noteworthy player in the biopharmaceutical landscape. With a current market..

Bausch Health Companies Inc. (BHC) Investor Outlook: Exploring a 9.48% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) has emerged as a compelling consideration for investors eyeing the healthcare sector, particularly within the specialty and generic drug manufacturing..

Organon & Co. (OGN) Stock Analysis: Exploring a Compelling 27% Potential Upside in the Healthcare Sector

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, commands attention from investors with its expansive portfolio of health solutions, ranging from women’s..

CONMED Corporation (CNMD) Stock Analysis: Navigating a 33.57% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, has recently caught the attention of investors. With a market cap..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 38.67% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the U.S. healthcare sector, offers a compelling investment opportunity with a potential upside of 38.67%, according..

Evotec SE (EVO) Stock Analysis: Unpacking a Potential 69.89% Upside for Investors

Evotec SE (EVO), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, has captured the attention of investors with its potential upside..

BGM Group Ltd. (BGM): A Healthcare Contender Amidst Market Challenges – Investor Outlook

BGM Group Ltd. (BGM), a player in China’s healthcare sector, is carving out its niche in the specialty and generic drug manufacturing industry. Despite operating in..

National HealthCare Corporation (NHC) Stock Analysis: Unpacking the Growth Potential in Healthcare Facilities

National HealthCare Corporation (NHC) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Murfreesboro, Tennessee, NHC has..

Brookdale Senior Living Inc. (BKD): Navigating Challenges with a 4.80% Revenue Growth in Healthcare

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Supernus Pharmaceuticals (SUPN): Investor Outlook on a Rising Biopharma Star with Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is carving out a notable niche within the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a..

Recursion Pharmaceuticals (RXRX) Stock Analysis: A Biotech Gem with 31.70% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery. Operating as a clinical-stage biotech company, Recursion..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a Potential 129.55% Upside

For investors with a keen eye on the biotechnology sector, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) presents a compelling opportunity with its substantial upside potential. The company,..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Highlights Robust Revenue Growth and Analyst Confidence

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company based in Foster City, California, has been capturing the attention of investors with its innovative approach to treating..

Artivion, Inc. (AORT) Stock Analysis: Navigating a 5.95% Potential Upside in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the medical devices industry, is drawing significant interest from investors eager to tap into its promising growth potential. With..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unpacking a Potential 712% Upside in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning force in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and the potential for significant..

Search

Funds

September 30, 2025

Search

Funds

September 30, 2025

FTSE 100

Funds